Daunorubicin, Dexamethasone, Imatinib, Methotrexate, Rituximab, and Vincristine
About
Membership operator: AND
Therapies: 6
Therapies
Daunorubicin (tx:ncit:C62091)
Dexamethasone (tx:ncit:C422)
Imatinib (tx:ncit:C62035)
Methotrexate (tx:ncit:C642)
Rituximab (tx:ncit:C1702)
Vincristine (tx:ncit:C933)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| HSE (1) | BCR::ABL1, CD20 + | Acute Lymphoblastic Leukemia | Daunorubicin, Dexamethasone, Imatinib, Methotrexate, Rituximab, Vincristine |